MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 591769 | Name: Undecanoate
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Undecanoate is used in Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure.

Chemical Structure

Undecanoate
Undecanoate
CAS#112-37-8

Theoretical Analysis

MedKoo Cat#: 591769

Name: Undecanoate

CAS#: 112-37-8

Chemical Formula: C11H22O2

Exact Mass: 186.1620

Molecular Weight: 186.30

Elemental Analysis: C, 70.92; H, 11.90; O, 17.18

Price and Availability

Size Price Availability Quantity
100g USD 230.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Undecanoate; NSC 7885; NSC-7885; NSC7885
IUPAC/Chemical Name
Undecanoic acid
InChi Key
ZDPHROOEEOARMN-UHFFFAOYSA-N
InChi Code
InChI=1S/C11H22O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2-10H2,1H3,(H,12,13)
SMILES Code
CCCCCCCCCCC(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 186.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M, García-Pavía P, Lupón-Rosés J, Roig-Minguell E, Comin-Colet J, Bayes-Genis A, Noguera JA, Pascual-Figal DA. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study. J Cardiovasc Pharmacol Ther. 2018 Jan 1:1074248418784020. doi: 10.1177/1074248418784020. [Epub ahead of print] PubMed PMID: 29929385. 2: Ng Tang Fui M, Hoermann R, Nolan B, Clarke M, Zajac JD, Grossmann M. Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial. Sci Rep. 2018 Jun 14;8(1):9099. doi: 10.1038/s41598-018-27481-3. PubMed PMID: 29904126. 3: Huh JS, Chung BH, Hong CH, Ryu JK, Kim JH, Han WK, Park KK. The effects of testosterone replacement on penile structure and erectile function after long-term castration in adult male rats. Int J Impot Res. 2018 May 4. doi: 10.1038/s41443-017-0010-6. [Epub ahead of print] PubMed PMID: 29725076. 4: DI HJ, Fan YF, Zhang HF, Liu KM, Liu C. [Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism]. Zhonghua Nan Ke Xue. 2017 Jun;23(6):517-521. Chinese. PubMed PMID: 29722943. 5: Mao JB, Chen XG, Gui DW, Peng W, Zheng J. [Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males]. Zhonghua Nan Ke Xue. 2017 May;23(5):455-458. Chinese. PubMed PMID: 29717839. 6: Groti K, Žuran I, Antonič B, Foršnarič L, Pfeifer M. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male. 2018 Apr 30:1-12. doi: 10.1080/13685538.2018.1468429. [Epub ahead of print] PubMed PMID: 29708829. 7: Zagarskikh EY, Proshchai GA, Vorokhobina NV. [Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes]. Urologiia. 2018 Mar;(1):92-95. Russian. PubMed PMID: 29634140. 8: Defreyne J, Vantomme B, Van Caenegem E, Wierckx K, De Blok CJM, Klaver M, Nota NM, Van Dijk D, Wiepjes CM, Den Heijer M, T'Sjoen G. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Andrology. 2018 May;6(3):446-454. doi: 10.1111/andr.12485. Epub 2018 Mar 30. PubMed PMID: 29602229. 9: Hua Y, Li W, Cheng Z, Zhao Z, Yin X, Li Y, Sun J, Gao J, Zhang H, Zheng A. Solidification of Nanostructured Lipid Carriers Loaded Testosterone Undecanoate: In Vivo and In Vitro Study. Drug Res (Stuttg). 2018 Mar 27. doi: 10.1055/a-0573-9132. [Epub ahead of print] PubMed PMID: 29589341. 10: Savkovic S, Lim S, Jayadev V, Conway A, Turner L, Curtis D, Goebel C, Handelsman DJ. Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2277-2283. doi: 10.1210/jc.2018-00054. PubMed PMID: 29584875. 11: Kotwal N, Upreti V, Nachankar A, Hari Kumar KVS. A Prospective, Observational Study of Osteoporosis in Men. Indian J Endocrinol Metab. 2018 Jan-Feb;22(1):62-66. doi: 10.4103/ijem.IJEM_414_16. PubMed PMID: 29535939; PubMed Central PMCID: PMC5838913. 12: Dimitriadis GK, Randeva HS, Aftab S, Ali A, Hattersley JG, Pandey S, Grammatopoulos DK, Valsamakis G, Mastorakos G, Jones TH, Barber TM. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy. Endocrine. 2018 Apr;60(1):175-184. doi: 10.1007/s12020-017-1516-x. Epub 2018 Feb 2. PubMed PMID: 29396841; PubMed Central PMCID: PMC5845623. 13: Halmenschlager G, Rhoden EL, Motta GA, Sagrillo Fagundes L, Medeiros JL Jr, Meurer R, Rhoden CR. Testosterone replacement maintains smooth muscle content in the corpus cavernosum of orchiectomized rats. Asian J Urol. 2017 Oct;4(4):223-229. doi: 10.1016/j.ajur.2017.02.001. Epub 2017 Feb 16. PubMed PMID: 29387554; PubMed Central PMCID: PMC5773047. 14: Ng Tang Fui M, Hoermann R, Grossmann M. Effect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet. J Endocr Soc. 2017 Feb 28;1(4):302-312. doi: 10.1210/js.2017-00062. eCollection 2017 Apr 1. PubMed PMID: 29264488; PubMed Central PMCID: PMC5686636. 15: Levcikova M, Breza J Jr, Luha J, Dubravicky J, Kovacova E, Fillo J. Testosterone replacement therapy (TRT) and its effect on bone marrow. How serious is it and is there a true polyglobulia? Bratisl Lek Listy. 2017;118(11):654-657. doi: 10.4149/BLL_2017_124. PubMed PMID: 29216720. 16: Lood Y, Aardal-Eriksson E, Webe C, Ahlner J, Ekman B, Wahlberg J. Relationship between testosterone in serum, saliva and urine during treatment with intramuscular testosterone undecanoate in gender dysphoria and male hypogonadism. Andrology. 2018 Jan;6(1):86-93. doi: 10.1111/andr.12435. Epub 2017 Nov 16. PubMed PMID: 29145707. 17: Correction to: Wolf et al., Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study. Aging Male. 2017 Dec;20(4):i. doi: 10.1080/13685538.2017.1380904. Epub 2017 Sep 28. PubMed PMID: 28956684. 18: Wolf J, Keipert D, Motazedi H, Ernst M, Nettleship J, Gooren L. Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study. Aging Male. 2017 Dec;20(4):225-234. doi: 10.1080/13685538.2017.1364234. Epub 2017 Aug 16. PubMed PMID: 28812471. 19: Hackett G, Cole N, Saghir A, Jones P, Strange RC, Ramachandran S. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Andrology. 2017 Sep;5(5):905-913. doi: 10.1111/andr.12399. Epub 2017 Aug 3. PubMed PMID: 28771964. 20: Krakowsky Y, Conners W, Davidson E, Rawji A, Morgentaler A. Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States. Urology. 2017 Nov;109:27-31. doi: 10.1016/j.urology.2017.07.007. Epub 2017 Jul 19. PubMed PMID: 28735014.

View History

Efatutazone hydrochloride

Efatutazone hydrochloride

UK 78624

UK 78624

Ulicyclamide

Ulicyclamide

Mantabegron hydrochloride

Mantabegron hydrochloride